Genomic Medicine Research Center (유전체맞춤의학연구센터)
Results 1-20 of 89 (Search time: 0.002 seconds).
No. | Year | Title | Type |
---|---|---|---|
89 | 2025 | 2025Patent 신규한 신남아마이드 유도체 및 이의 용도KR10-2022-0076360 (2022.06.22) / 10-2811597 (2025.05.19)권병목; 한동초; 이유진; 최지연; 박경찬; 박성환 |
Patent |
88 | 2025 | 2025Article 2'-Hydroxycinnamaldehyde induces ROS-mediated apoptosis in cancer cells by targeting PRX1 and PRX2Results in Chemistry, vol. 13, pp. 101931-101931Yae Jin Yoon; Yu-Jin Lee; Jiyeon Choi; Seung-Wook Chi; Sangku Lee; Kyung Chan Park; Byoung-Mog Kwon; Dong Cho Han |
Article |
87 | 2025 | 2025Article Towards understanding cancer dormancy over strategic hitching up mechanisms to technologiesMolecular Cancer, vol. 24, pp. 47-47S Yang; Jieun Seo; J Choi; S H Kim; Yunmin Kuk; Kyung Chan Park; M Kang; Sangwon Byun; J Y Joo |
Article |
86 | 2025 | 2025Article Anti-proteolytic regulation of KRAS by USP9X/NDRG3 in KRAS-driven cancer developmentNature Communications, vol. 16, pp. 628-628Han Koo; Kyung Chan Park; Hyun Ahm Sohn; Minho Kang; D J Kim; Z Y Park; S Park; S H Min; Seong-Hwan Park; Yeon Mi You, et al. |
Article |
85 | 2025 | 2025Research Project 탈메틸화 효소 JMJD3의 후성유전학적 콜레스테롤 대사 조절 기능 및 죽상동맥경화증 치료기술 연구 = A study on the epigenetic regulation of cholesterol metabolism by histone demethylase JMJD3 and treatment of atherosclerosis연구책임자 : 변상원 / 사업기간 : 2025.03.01 ~ 2026.02.28 |
Research Project |
84 | 2025 | 2025Research Project 바이오 빅데이터 기반 난치성 암 맞춤의약 원천기술 개발 = Bio big-data driven study for targeted therapy of currently untreatable cancers연구책임자 : 김선영 / 사업기간 : 2025.01.01 ~ 2025.12.31 |
Research Project |
83 | 2025 | 2025Research Project 췌장암 휴면성 예측을 위한 원천기술 개발 및 치료 전략 제시 = Development of experimental model to predict dormant progression of pancreatic cancer and treatment strategies연구책임자 : 유원백 / 사업기간 : 2025.05.01 ~ 2026.04.30 |
Research Project |
82 | 2025 | 2025Research Project KRAS 안정성 조절인자 NDRG3 표적화 췌장암 제어용 이중기능성 유효/선도물질 도출연구책임자 : 이동철 / 사업기간 : 2025.01.01 ~ 2025.04.30 |
Research Project |
81 | 2024 | 2024Patent 벤즈이미다졸 유도체를 유효성분으로 함유하는 암 예방 또는 치료용 약학적 조성물KR10-2021-0113677 (2021.08.27) / 10-2740381 (2024.12.04)염영일; 이동철; 박경찬; 구한; 김차연 |
Patent |
80 | 2024 | 2024Patent SYT11 억제제를 유효성분으로 포함하는 위암 치료용 조성물CN201980068374.8 (2021.04.16) / ZL201980068374.8 (2024.08.20)원미선; 김보경; 반현승; 박경찬; 염영일 |
Patent |
79 | 2024 | Patent | |
78 | 2024 | 2024Patent 신규한 피리미딘-4-온 화합물 및 이를 포함하는 항암제 조성물KR10-2021-0095927 (2021.07.21) / 10-2649886 (2024.03.18)염영일; 박경찬; 이동철 |
Patent |
77 | 2024 | 2024Research Project 췌장암 휴면성 예측을 위한 원천기술 개발 및 치료 전략 제시 = Development of experimental model to predict dormant progression of pancreatic cancer and treatment strategies연구책임자 : 유원백 / 사업기간 : 2024.05.01 ~ 2025.04.30 |
Research Project |
76 | 2024 | 2024Research Project 바이오 빅데이터 기반 난치성 암 맞춤의약 원천기술 개발 = Bio big-data driven study for targeted therapy of currently untreatable cancers연구책임자 : 박경찬 / 사업기간 : 2024.01.01 ~ 2024.12.31 |
Research Project |
75 | 2024 | 2024Research Project KRAS 안정성 조절인자 NDRG3 표적화 췌장암 제어용 이중기능성 유효/선도물질 도출연구책임자 : 이동철 / 사업기간 : 2024.01.01 ~ 2024.12.31 |
Research Project |
74 | 2024 | 2024Article Role of SYT11 in human pan-cancer using comprehensive approachesEuropean Journal of Medical Research, vol. 29, pp. 338-338Kyunghee Noh; Hyunji Choi; Eun-Hye Jo; Wonbeak Yoo; Kyung Chan Park |
Article |
73 | 2024 | 2024Research Project 암대사형 악성 진화 유도인자 발굴과 분자기전 규명연구책임자 : 박경찬 / 사업기간 : 2024.06.11 ~ 2025.01.31 |
Research Project |
72 | 2024 | 2024Article CRHBP, a novel multiple cancer biomarker connected with better prognosis and anti-tumorigenicityCancer Cell International, vol. 24, pp. 391-391Wonbeak Yoo; Hyunji Choi; Jieun Lee; Yeeun Lee; Kyung Chan Park; Kyung Hee Noh |
Article |
71 | 2024 | 2024Article Proteogenomic characterization reveals estrogen signaling as a target for never-smoker lung adenocarcinoma patients without EGFR or ALK alterationsCancer Research, vol. 84, no. 9, pp. 1491-1503Seung-Jin Park; S Ju; S H Goh; Byoung-Ha Yoon; Jong Lyul Park; Jeong Hwan Kim; S Lee; S J Lee; Y Kwon; W Lee, et al. |
Article |
70 | 2024 | 2024Research Project 특정이자 활용사업(바이오의약연구부) = 특정이자 활용(바이오의약연구부)연구책임자 : 지승욱 / 사업기간 : 2024.03.18 ~ 2024.12.31 |
Research Project |